approval
saveBRAFTOVI (ENCORAFENIB) — FDA approval
community read0 votes
Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalFeb 24, 2026 · 269d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalFeb 24, 2026 · 269d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalDec 20, 2024 · 700d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalSep 12, 2024 · 799d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalOct 13, 2023 · 1134d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalOct 11, 2023 · 1136d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalFeb 11, 2022 · 1743d ago
- approvalBRAFTOVI (ENCORAFENIB) — FDA approvalApr 8, 2020 · 2417d ago
comments(0)
5-min edit window · permanent after that